Pilot study of interferon-alpha-ribavirin-interleukin-2 for treatment of nonresponder patients with severe liver disease infected by hepatitis C virus genotype 1. [electronic resource]
Producer: 20060331Description: 139-44 p. digitalISSN:- 1352-0504
- Antiviral Agents -- administration & dosage
- Drug Therapy, Combination
- Female
- France
- Hepacivirus -- genetics
- Hepatitis C, Chronic -- drug therapy
- Humans
- Injections, Subcutaneous
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Interleukin-2 -- administration & dosage
- Male
- Middle Aged
- Pilot Projects
- Recombinant Proteins
- Ribavirin -- administration & dosage
- Species Specificity
- Treatment Outcome
- Viral Load
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.